Post-Polio References

These are references cited in the article "Parallels Between Post-Polio Fatigue and Chronic Fatigue Syndrome: A Common Pathophysiology?" by Richard L. Bruno, Ph.D.1 , Susan J. Creange, Ph.D., and Nancy M. Frick, Lh.D. Due to copyright, I cannot make the article directly available. It is in American Journal of Medicine, 1998, 105 (3A): 66-73.

References

  1. Parsons PE National Health Interview Survey Washington, DC: National Center for Health Statistics, 1989.
  2. Bruno RL, Frick NM Stress and “Type A” behavior as precipitants of Post-Polio Sequelae In LS Halstead and DO Wiechers (Eds.) Research and Clinical Aspects of the Late Effects of Poliomyelitis White Plains: March of Dimes Research Foundation, 1987.
  3. Bruno RL, Frick NM, Cohen J. Polioencephalitis, stress and the etiology of Post-Polio Sequelae. Orthopedics 1991;14(11):1269-1276.
  4. Trojan D, Gendron T, Cashman NR. Electrophysiology and electrodiagnosis of the post-polio motor unit Orthopedics 1991;14:1353-1361.
  5. Bodian D. Poliomyelitis: Neuropathologic observations in relation to motor symptoms. JAMA 1947;134: 1148-1154.
  6. Guizetti HU. Betrachtungen zur poliomyelitis des hirnstammes. Deutsch Ztschr f Nervenh 1933;131: 29-42.
  7. Bodian D. Histopathological basis of clinical findings in poliomyelitis. Am J Med 1949;6:563-578.
  8. Barnhart M, Rhines R, McCarter JC, HW Magoun. Distribution of lesions of the brain stem in poliomyelitis. Arch Neurol Psychiatry 1948;59: 368-377.
  9. Matzke HA, Baker AB. Poliomyelitis: A study of the midbrain. Arch Neurol Psychiatry 1951;65:1-15.
  10. Peers JH. The pathology of convalescent poliomyelitis in man. Am J Pathol1942;19:673-695.
  11. Luhan JA. Epidemic poliomyelitis: Some pathological observations on human material. Arch Pathol 1946;42: 245-260.
  12. Howe HA, Bodian D. Neural Mechanisms of Poliomyelitis. New York, NY: The Commonwealth Fund, 1942.
  13. Morruzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. EEG Clin Neurophysiol 1949;1: 455-473.
  14. Bentivoglio M, Steriade M. Brainstem-diencephalic circuits as a structural substrate of the ascending reticular activation concept. In M Mancia and G Marini (Eds.) The Diencephalon and Sleep. New York, NY: Raven Press, 1990.
  15. Sakai K, El Mansari M , Lin JS , et al. The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. In M Mancia and G Marini (Eds.) The Diencephalon and Sleep. New York, NY: Raven Press, 1990.
  16. Mesulam M-M. Attention, confusional states, and neglect. In M-M Mesulam (Ed) Principles of Behavioral Neurology. Philadelphia, PA: Davis, 1985.
  17. Pribram KH, McGuinness D. Attention and para-attentional processing: Event-related brain potentials as tests of a model. Ann NY Acad Sci 1992;658: 65-92.
  18. Jones BE. Influence of the brainstem reticular formation, including intrinsic mono- aminergic and cholinergic neurons, on forebrain mechanisms of sleep and waking. In M Mancia and G Marini (Eds.) The Diencephalon and Sleep. New York, NY: Raven Press, 1990.
  19. Robbins TW. Psychopharmacological and neurobiological aspects of the energetics of information processing In GRJ Hockey, AWK Gaillard, MGH Coles (Eds.) Energetics and Human Information Processing. Dordrecht: Martinus Nijhoff, 1986.
  20. Mandell AJ. Toward a psychobiology of transcendence. In JM Davidson and RJ Davidson (Eds.) The Psychobiology of Consciousness. New York, NY: Plenum, 1980.
  21. Brown JR, Baker AB, McQuarrie I , et al. The Bulbar form of poliomyelitis. JAMA 1947;135: 425-428.
  22. Baker AB, Neurologic signs of bulbar poliomyelitis. In Poliomyelitis Philadelphia, PA: Lippincott, 1949.
  23. Holmgren BE. Electro-encephalography in poliomyelitis In Poliomyelitis Philadelphia, PA: Lippincott, 1952.
  24. Meyer E. Psychological considerations in a group of children with poliomyelitis. J Pediatrics 1947;31: 34- 48.
  25. Bruno RL, Galski T, DeLuca J. Neuropsychology of Post-Polio Fatigue. Arch Phys Med Rehabil 1993;74: 1061-1065.
  26. Behan PO, Behan WMH. Postviral fatigue syndrome. CRC Critical Reviews in Neurobiology 1988;4: 157- 178.
  27. Buchwald DPR, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue neurologic and immunologic disorders and active human herpesvirus type 6 infection. Ann Int Med 1992;116:103-113.
  28. Hyde BM. Myalgic Encephalomyelitis (Chronic Fatigue Syndrome): An historical perspective. In BM Hyde J Goldstein, P Levine (Eds.) The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome . Ottawa, Ontario: The Nightingale Research Foundation, 1992.
  29. Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. Brit Med J 1951;2:77-81.
  30. Barrett AM, Gardner D, McFarlan AM. An outbreak of encephalitis, possibly due to poliomyelitis virus. Brit Med J 1952;1:1317-1322.
  31. Magoun HW. In Poliomyelitis Philadelphia, PA: Lippincott, 1949, p 250.
  32. Duvoisin RC, Yahr MD. Encephalitis and parkinsonism Arch Neurol 1965;12:227-239.
  33. Heilman KM, Voeller KKS, Nadeau SE. A possible pathophysiologic substrate of attention deficit hyperactivity disorder. J Child Neurol 1991; 6 (Suppl):S74-S79.
  34. Denny-Brown D, Yanagisawa N. The role of the basal ganglia in the initiation of movement. In MD Yahr (Ed.) The Basal Ganglia. New York, NY: Raven, 1976.
  35. Owen AM, Roberts AC, Hodges JR, et al. Contrasting mechanisms if impaired attentional set-shifting in patients with frontal lobe damage or Parkinson’s disease. Brain 1993;116:1159-1175.
  36. Echiverri HC, Tatum WO, Merens TA, Coker SB. Akinetic mutism. Pediatric Neurol 1988;4:228-230.
  37. Bowen FP. Behavioral alterations in patients with basal ganglia lesions. Research Publications: Assoc Res Nerv Ment Dis 1976;55:169-180.
  38. Brown RG, Marsden CD. Cognitive function in ParkinsonÕs disease. TINS 1990;1:21-28.
  39. Hilten JJ van, Hoogland G, van der Velde EA , et al. Diurnal effects of motor activity and fatigue in ParkinsonÕs disease. J Neurol Neurosurg Psychiatry 1993;56:874-877.
  40. Friedman J, Friedman H. Fatigue in ParkinsonÕs disease.. Neurology 1993;43:2016-2018.
  41. Naville F. Encephale 1922;17:369-375.
  42. Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland Disease and epidemic neuromyasthenia. Am J Med 1959;26: 569-595.
  43. Hyde BM, Bergman S. Chronic aspects of Akureyri Disease. In R Jenkins and JF Mowbray (Eds.) Post-Viral Fatigue Syndrome. Chichester: John Wiley & Sons, 1991.
  44. Ramsay AM, OÕSullivan E . Encephalomyelitis simulating poliomyelitis. Lancet i: 1956;762- 767.
  45. Galpine JF, Brady. Benign myalgic encephalomyelitis. Lancet 1957;i:757-758.
  46. Daikos GK, Garzonis S, Paleologue A, et al. Benign myalgic encephalomyelitis. Lancet 1959;i: 693-696.
  47. Macrae AD, Galpine JF. An illness resembling poliomyelitis observed in nurses. Lancet 1954;ii: 350-352.
  48. Gilliam AG. Epidemiological study of an epidemic, diagnosed as poliomyelitis, occurring among the personnel of the Los Angeles County General Hospital during the summer of 1934. US Public Health Bull 1938; (No 240): 1-90.
  49. Gsell VO. Abortive poliomyelitis. Helvetica Medica Acta 1949;3/4:169-183.
  50. Fog T. Vegetative (epidemic?) neuritis. Ugeskr Laeg 1953;115: 1244-1248.
  51. Pellew RA. Clinical description of a disease resembling poliomyelitis seen in Adelaide. Med J Aust 1951;1: 944-946.
  52. White DN, Burtch RB. Iceland Disease: A new infection simulating acute anterior poliomyelitis. Neurology 1954;4: 506-516.
  53. Deisher JB. Benign myalgic encephalomyelitis (Iceland Disease) in Alaska. Northwest Med 1957;56: 1451- 1456.
  54. Sigurdsson B, Sigurjonsson J, Sigurdsson HJ, et al. A disease epidemic in Iceland simulating poliomyelitis. Am J Hyg 1950;52:222-238.
  55. Sigurdsson B, Gudmundsson KR. Clinical findings six years after outbreak of Akureyri Disease. Lancet 1957;i: 766-767.
  56. Sigurdsson B, Gudnadottir M, Petursson G. Response to poliomyelitis vaccination. Lancet 1958;i: 370-371.
  57. Hart RH. Epidemic neuromyesthenia. N Eng J Med 1969;281:797.
  58. Henderson DA, Shelokov A. Epidemic neuromyesthenia. N Eng J Med 1959;260:757-764.
  59. Hyde BM, Jain A. Clinical observations of central nervous system dysfunction in post- infectious, acute onset ME/CFS. In BM Hyde J Goldstein, P Levine (Eds.) The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome . Ottawa, Ontario: The Nightingale Research Foundation, 1992.
  60. Altay HT, Toner BB, Brooker H, et al. The neuropsychological dimensions of postinfectious neuromyesthenia. IntÕl J Psychiatry in Med 1990;20:141-149.
  61. Jamal GA. Evidence for organic disturbance in Post Viral Fatigue Syndrome. In BM Hyde J Goldstein, P Levine (Eds.) The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome . Ottawa, Ontario: The Nightingale Research Foundation, 1992.
  62. DeLuca J, Johnson SK, Natelson BH. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis Arch Neurol 1993;50: 301-304.
  63. Sandman CA, Barron JL, Nackoul K , et al. Memory deficits associated with chronic fatigue immune dysfunction syndrome. Biol Psychiatry 1993;33:618-623.
  64. Lonnberg F. Late onset polio sequelae in Denmark. Scand J Rehab Med 1993;Suppl 28: 1-32.
  65. McDonald E, Cope H, David A. Cognitive impairment in patients with chronic fatigue. J Neurol Neurosurg Psychiatry 1993;56:812-815.
  66. Graffman J, Schwartz V, Dale JK, et al. Analysis of neuropsychological functioning in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1991;56:684-689.
  67. Bruno RL, Cohen J, Galski T, Frick NM. The neuroanatomy of post-polio fatigue. Arch Phys Med Rehabil 1994;75:498-504.
  68. Wasserstrom R, Mamourian AC, McGary CT, Miller G. Bulbar poliomyelitis: MR findings with pathological correlation. AJNR 1992;13:371-373.
  69. Parasuraman R, Nestor P. Energetics of attention and AlzheimerÕs Disease In GRJ Hockey, AWK Gaillard, MGH Coles (Eds.) Energetics and Human Information Processing. Dordrecht: Martinus Nijhoff, 1986.
  70. Howe HA, Bodian D. Neuropathological evidence on the portal of entry problem in human poliomyelitis. Bull Johns Hopkins Hosp 1941;69:183-214.
  71. Bodian D, Howe HA. Neurotropism and the genesis of cerebral lesions in poliomyelitis. Bull Johns Hopkins Hosp 1941;68: 58-76.
  72. Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: Possible pathological basis. Radiology 1987;162:509-511.
  73. Daugherty SA, Henry BE, Peterson DL, et al. Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 1991;13 (Suppl 1):S39-44.
  74. Almkvist O, Wahlund L-O, Anderson-Lundman G, et al. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-632.
  75. Kertesz A, Polk M , Carr T. Cognition and white matter changes on magnetic resonance imaging in dementia Arch Neurol 1990;47:387-391.
  76. Austron MG, Thompson RF, Hendrie HC, et al. Foci of increased T2 signal intensity in MR images of healthy elderly subjects: A follow-up study. J Am Geriatr Soc 1990;38:1133-1138.
  77. Boone KB, Miller BL, Lesser IM , et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. Arch Neurol 1992;49:549-554.
  78. Junque C, Pujol J , Vendrell P, et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990;47:151-156.
  79. Roelcke U, Kappos L, Lechner-Scott J, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue. Neurol 1997;48:1566-1571.
  80. Gupta KL, Shetty KR, Rudman IW, Rudman D. Impaired nocturnal growth hormone secretion with age in post- polio syndrome. Clin Res 1992;40:688.
  81. Neubuerger KT. Bulbar poliomyelitis. In Poliomyelitis Philadelphia, PA: Lippincott, 1949.
  82. Petrusz P, Merchenthaler I. The corticotropin-releasing factor system In CB Nemeroff (Ed.) Neuroendocrinology . Boca Raton, FL: CRC Press, 1992.
  83. Meyerhoff JL, Mougey EH, Kant GJ. Paraventricular lesions abolish the stress-induced rise in pituitary cyclic AMP and attenuate the increases in plasma levels of proopiomelanocortin-derived peptides and prolactin. Neuroendocrinology 1987;46:222-230.
  84. Dallman MF, Strack A , Akana S, et al. Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow. Frontiers in Neuroendocrinology 1993;14:303-347.
  85. Bruno RL, Sapolsky R, Zimmerman JR, Frick NM. The pathophysiology of a central cause of post-polio fatigue. Ann NY Acad Sci 1995;753: 257-275.
  86. Moodradian AD. Geriatric Neuroendocrinology. In CB Nemeroff (Ed.) Neuroendocrinology . Boca Raton, FL: CRC Press, 1992.
  87. Miller LH, Kastin AJ, Sandman CA, et al. Polypeptide influences on attention, memory and anxiety in man. Pharm Biochem & Beh 1974;2: 663-668.
  88. Reinberg A, Briere L, Fraboulet G, et al. Clinical chronobiology of ACTH 1-17. Chronobiologia 1981;8:101-115.
  89. Strand FL, Cayer A , Gonzalez E, Stoboy H. Peptide enhancement of neuromuscular function. Pharm Biochem & Beh 1976;5 (Suppl 1):179-187.
  90. Van Wimersma Greidanus Tj B, de Wied. Effects of systemic and intracerebral administration of two opposite acting ACTH-related peptides on extinction of conditioned avoidance behavior. Neuroendocrinology 1971;7:291-301.
  91. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinology Metabolism 1991;73: 1224-1234.
  92. Majeed T, Dinan TG, Behan PO. Ipsaprione induced ACTH release – Evidence of impaired activation of the HPA axis in patients with CFS. Proceedings of the First World Congress of Chronic Fatigue Syndrome and Related Disorders: Brussels, 1995, page 103.
  93. Bruno RL, Frick NM, Creange SJ, et al. Polioencephalitis and the brain fatigue generator model of post-viral fatigue syndromes. Journal of Chronic Fatigue Syndrome 1996;2:5-27.
  94. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Q J Med 1995;88:767-773.
  95. Tavio M, Chierochetti F, Bianchini B, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: A useful tool for differential diagnosis. Proceedings of the American Association for Chronic Fatigue Syndrome Conference . San Francisco: AACFS, 1996.
  96. Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognized cause of chronic fatigue syndrome? Lancet 1995; 345:623-624.
  97. Bou-Holaigah I, Rowe PC, Kan JS, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-967.
  98. Lapp CW. NMH, SOTS and CFS. Proceedings of the American Association for Chronic Fatigue Syndrome Conference. San Francisco: AACFS, 1996.
  99. Bruno RL. Chronic fatigue, fainting and autonomic dysfunction: Further similarities between post-polio Fatigue and Chronic Fatigue Syndrome? J Chronic Fatigue Syndrome 1997; 3:107-117.
  100. Bruno RL. Fainting and Fatigue: Causation or Coincidence? CFIDS Chronicle 1996;9 (2): 37-39.
  101. McQuarie I. The evolution of signs and symptoms of poliomyelitis. In Poliomyelitis . Philadelphia, PA: Lippincott, 1949, pp.57-61.
  102. Bakheit A. Abnormal arginine-vasopressin secretion and water metabolism in patients with post-viral fatigue syndrome. Acta Neurol Scand 1993;87:234-238.
  103. Pan J-T. Neuroendocrine functions of dopamine. In T W Stone (Ed.) CNS neurotransmitters and neuromodulators: Dopamine. Boca Raton: CRC Press, 1996:213-232.
  104. Valentino DA, Arruda JE, Gold SM. Comparison of QEEG and response accuracy in good vs poor performers during a vigilance task. Int J Psychophysiol 1993;15:123-134.
  105. O’Hanlon JF, Beatty J. Concurrence of electroencephalographic and performance changes during a simulated radar watch and some implications for the arousal theory of vigilance. In RR Mackie (Ed.) Vigilance. New York: Plenum, 1977, pp.189-201.
  106. Bruno RL, Creange SJ, Zimmerman JR, Frick NM. Elevated plasma prolactin and EEG slow wave power in post-polio fatigue: Implications for a dopamine deficiency underlying chronic fatigue syndromes. J Chronic Fatigue Syndrome 1998 (in press).
  107. Bruno RL The psychology and psychology of the post-polio brain Keynote address, International Post-Polio Conference, Calgary: October, 1997.
  108. Marcel B, Komaroff AL, Fagioli LR, et al. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psychiatry, 1996; 40:535-541.
  109. Bruno RL, Zimmerman JR, Creange SJ, Lewis T, Molzen T, Frick NM. Bromocriptine in the treatment of post- polio fatigue: A pilot study with implications for the pathophysiology of fatigue. Am J Phys Med Rehabil 1996; 75 (5): 340-347.
  110. Fagan D, Scott DD, Mitchell M, Tiplady B. Effects of remoxipride on measures of psychological performance in healthy volunteers. Psychopharmacology 1991;105:225-229.
  111. Gear JHS. Non polio causes of polio like paralytic syndrome. Review of Infectious Diseases 1984; 66:379- 382.
  112. Shindarov LM, Chumakov MP, Voroshilava MK, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hygiene Epidemiol Microbiol 1979; 3:284-295.
  113. Dowsett EG. Human enteroviral infections. J Hospital Infections 1988;11:103-115.
  114. Heathfield KWG, Pilsworth R, Wall BJ, Corsellis JAN. Coxsackie B5 infection in Essex, 1965, with particular reference to the nervous system. Q J Med 1967; 36:579-595.
  115. Vorashilova MK, Chumakov MP. Poliomyelitis-like properties of AB-IV coxsackie A-7 group of viruses. Prog Med Virol 1959; 21:106-110.
  116. Grist NR. Type A7 Coxsackie (Type IV poliomyelitis) viral infection in Scotland. J Hygiene (Cambridge) 1962, 60: 323-325.
  117. Tuteja U, Pandya G, Bharagava R, et al. Enterovirus specific IgM responses in children with acute and chronic paralytic syndrome. J Tropical Med and Hygiene 1995; 98: 367-372.

Leave a Reply